https://www.timesnownews.com/leaders-of-tomorrow/leaders-of-tomorrow-season-11-bharat-biotech-part-2-video-100292415
Leaders of Tomorrow | Season 11 | Bharat Biotech | Part 2 | Times Now
May 17, 2023 - In this episode of Leaders of Tomorrow, we speak with Suchitra Ella, MD, Bharat Biotech, a trailblazer paving the way in a world dominated by foreign...
leaders of tomorrowseason 11bharat biotechpart 2
https://www.gsk.com/en-gb/media/press-releases/gsk-licenses-shigella-vaccine-candidate-to-bharat-biotech-for-continued-development/
GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development | GSK
GSK plc announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech International Limited.
bharat biotechgsklicensesshigellavaccine
https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-covid-corona-vaccine-covaxin-booster-shot-trial-six-months-sec-1786317-2021-04-02
Bharat Biotech to begin Phase-2 trials of Covid vaccine Covaxin booster
Apr 2, 2021 - Bharat Biotech is set to initiate Phase-2 clinical trials of a third booster dose of its Covid-19 vaccine Covaxin.
bharat biotechphase 2
https://www.dnaindia.com/india/video-foreign-envoys-visit-bharat-biotech-plant-in-hyderabad-2860944
Foreign envoys visit Bharat Biotech plant in Hyderabad
64 foreign envoys visited at Bharat Biotech plant in Hyderabad on December 9. They took a tour of facility where COVID-19 vaccine, Covaxin is being developed....
bharat biotechforeignenvoysplanthyderabad
https://www.wionews.com/tags/bharat-biotech
Bharat Biotech News - Latest Bharat Biotech News, Breaking Bharat Biotech News, Bharat Biotech News...
Get top and latest Bharat Biotech News - Read Breaking Bharat Biotech News and Bharat Biotech News Headlines. WION is leading news channel worldwide get all...
bharat biotechnews latestbreaking
https://www.newindianexpress.com/nation/2023/feb/05/bharat-biotech-dispatches-three-lakh-nasal-vaccine-to-private-hospitals-2544639.html
Bharat Biotech dispatches three lakh nasal vaccine to private hospitals
The vaccine is now available on CoWIN and priced at Rs 800 for private markets and Rs 325 for the state and central government.
bharat biotechnasal vaccinedispatchesthreelakh
https://www.premiumtimesng.com/tag/bharat-biotech
Bharat Biotech Archives | Premium Times Nigeria
bharat biotechpremium timesarchivesnigeria
https://www.newindianexpress.com/states/telangana/2020/aug/24/covid-19-bharat-biotech-gets-nod-for-covaxin-clinical-trials-through-skin-2187390.html
COVID-19: Bharat Biotech gets nod for Covaxin clinical trials through skin
It also helps in reducing per-injection cost of vaccines and is also found to be more effective in inducing immune response.
covid 19bharat biotech
https://www.deccanherald.com/tags/bharat-biotech
Bharat Biotech
Read stories listed under on Bharat Biotech
bharatbiotech
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/chinese-hackers-attacked-it-systems-of-indian-covid-vaccine-makers-serum-institute-bharat-biotech-report-1774494-2021-03-01
Chinese hackers attacked IT systems of Indian Covid vaccine makers Serum Institute, Bharat Biotech:...
Mar 2, 2021 - A Singapore-based cyber intelligence firm has reportedly found that Chinese hackers recently targetted databases of Indian Covid vaccine makers -- Serum...
https://www.indiatimes.com/news/india/bharat-biotech-seeks-approval-for-trials-of-covaxin-booster-dose-for-2-18-years-age-group/articleshow/127361573.html
Bharat Biotech Seeks Approval For Trials Of Covaxin Booster Dose For 2-18 Years Age Group
Hyderabad-based pharma company Bharat Biotech, the makers of the first indigenous COVID-19 vaccine, Covaxin has reportedly sought permission from the Drugs...
https://www.business-standard.com/article/companies/bharat-bio-s-intranasal-vaccine-approved-for-mix-and-match-booster-dosing-122112800960_1.html
Bharat Biotech gets nasal vaccine nod for use as mix-match booster | Company News - Business...
iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us
https://www.indiatvnews.com/news/india/bharat-biotech-concludes-phase-3-covaxin-trial-claims-77-8-efficacy-against-covid-19-716478
Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19 | India News...
Jul 3, 2021 - Covaxin gives 77.8 per cent efficacy against COVID 19, and 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant
https://www.indiatoday.in/coronavirus-outbreak/story/coronavirus-vaccine-update-icmr-covaxin-ready-june-2021-bharat-biotech-1734657-2020-10-24
Coronavirus vaccine update: ICMR-backed Covaxin to be ready by June 2021, says Bharat Biotech -...
Oct 24, 2020 - In the latest update on coronavirus vaccine, Covaxin, which is backed by the Indian Council for Medical Research and being developed by Bharat Biotech, is...
https://www.india.com/news/india/bharat-biotech-completes-trials-for-indias-first-intranasal-covid-vaccine-calls-it-safe-and-immunogenic-5573567/
Bharat Biotech Completes Trials for India's First Intranasal Covid Vaccine, Calls It Safe and...
Aug 15, 2022 - According to the company, BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
https://www.indiatvnews.com/news/india/covaxin-emergency-use-listing-decision-likely-in-4-to-6-weeks-who-bharat-biotech-latest-news-718249
Covaxin emergency use listing decision likely in 4 to 6 weeks WHO bharat biotech latest news |...
Jul 10, 2021 - The World Health Organization (WHO) is likely to take a decision on India's only indigenously developed vaccine in use so far, Bharat Biotech's COVID-19...
https://www.straitstimes.com/asia/south-asia/bharat-biotechs-covid-19-shot-50-per-cent-effective-at-height-of-india-infections
Bharat Biotech's Covid-19 shot 50 per cent effective at height of India infections: Small study |...
Nov 24, 2021 - BENGALURU (REUTERS) - Bharat Biotech's vaccine was only 50 per cent effective at preventing symptomatic Covid-19 in a high-risk population during a devastating...
https://www.livemint.com/news/india/covaxin-india-extends-shelf-life-of-bharat-biotech-s-covid-vaccine-to-12-months-11635933943649.html?ref=drishtikone.com
Covaxin: India extends shelf life of Bharat Biotech's Covid vaccine to 12 months | Today News
Nov 3, 2021 - Currently, the shelf life of the vaccine is 6 months from the date of manufacture
https://www.business-standard.com/article/current-affairs/covaxin-showed-81-interim-efficacy-bharat-biotech-on-phase-3-results-121030300966_1.html
Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results | Current Affairs News...
Covaxin demonstrates significant immunogenicity against the rapidly emerging variants, says Bharat Biotech CMD
https://www.indiatimes.com/news/india/bharat-biotechs-nasal-covid-vaccine-approved-for-booster-dose-to-be-available-in-private-hospitals/articleshow/127149415.html
Bharat Biotech's Nasal COVID Vaccine Approved For Booster Dose, To Be Available In Private Hospitals
The Union Health Ministry on Friday approved Bharat Biotech's intranasal COVID-19 vaccine as a booster dose for those above 18 years of age. In November, the...
https://www.telegraphindia.com/india/biological-e-bharat-biotech-together-sitting-on-stockpile-of-250-million-covid-19-vaccine-doses/cid/1906353
COVID-19 | Biological E, Bharat Biotech together sitting on stockpile of 250 million Covid-19...
According to respective company sources, 200 million doses of Corbevax while 50 million doses of Covaxin are ready to dispatch as and when orders are received
https://www.ndtv.com/india-news/bharat-biotechs-covaxin-allowed-for-trial-on-children-above-age-12-2347370
COVID-19 Vaccine: Bharat Biotech Allowed To Conduct Vaccine Trials On Children Above 12
Bharat Biotech, which received emergency approval for its Covid-19 vaccine only in "clinical trial mode", is allowed to conduct its trials on children who are...
covid 19 vaccine
https://www.business-standard.com/article/current-affairs/bharat-biotech-s-covaxin-roll-out-for-children-likely-in-phases-121101901645_1.html
Bharat Biotech's Covaxin roll-out for children likely in phases | Coronavirus Latest News -...
Vaccine performance, availability being evaluated
https://www.livemint.com/market/ipo/bharat-biotech-ipo-soon-vaccine-maker-plans-to-raise-500-million-from-stock-market-says-report-11772208161131.html
Bharat Biotech IPO soon? Vaccine maker plans to raise $500 million from stock market, says report |...
Feb 27, 2026 - Bharat Biotech is seeking to raise over $500 million through an IPO. Discussions are ongoing, and details may change. Established in 1996, the company has...
https://www.wionews.com/india-news/ahead-of-who-bharat-biotech-meet-on-covaxin-key-stakeholders-come-together-387148
Ahead of WHO-Bharat Biotech meet on Covaxin, key stakeholders come together - India News News
https://www.timesnownews.com/health/article/bharat-biotech-to-manufacture-ten-types-of-vaccines-including-covaxin-in-odisha/678535
Bharat Biotech to manufacture ten types of vaccines, including Covaxin, in Odisha | Health Tips and...
The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies,...
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/expert-panel-recommends-bharat-biotech-s-covaxin-for-emergency-use-dcgi-to-take-final-call-1755318-2021-01-02
Bharat BioTech's Covaxin gets expert panel's recommendation for emergency use, DCGI to take final...
Jan 3, 2021 - A govt-appointed expert panel has recommended that Bharat BioTech's Covid-19 vaccine, Covaxin, should be given restricted emergency use in India.
https://www.gadgets360.com/internet/news/vaccine-makers-serum-institute-bharat-biotech-hacked-by-china-cyfirma-report-covaxin-covishield-2381401
COVID-19 Vaccine Makers Serum Institute of India, Bharat Biotech Targeted by Chinese Hackers:...
Mar 1, 2021 - Indian COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech have been targeted by a Chinese state-backed hacking group, cyber intelligence...
serum institute of indiacovid 19 vaccine
https://www.indiatimes.com/news/india/bharat-biotechs-covaxin-effectively-neutralises-alpha-delta-covid-variants-finds-us-study/articleshow/127538372.html
Bharat Biotech's COVAXIN Effectively Neutralises Alpha, Delta COVID Variants, Finds US Study
In some good news for India's fight against COVID-19, a study by the US' National Institute of Health has found that COVAXIN, the indigenous vaccine can...
https://www.wionews.com/india-news/bharat-biotechs-covid-vaccine-covaxin-gets-emergency-use-listing-from-who-panel-426431
Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel - India News News